Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors
Clinical trial NCT02923466 · COMPLETED
Trial details
- NCT number
- NCT02923466
- Sponsor
- Vyriad, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-17
- Primary completion
- 2022-02-05
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.